September Global Macro Monthly - Supply constraints add to inflation angst
- 22 September 2021 (10 min read)
Key points
- The EU’s “Fit for 55” programme is a suite of measures to deliver a 55% reduction in GHG emissions by 2030. It includes the Emissions Trading Scheme (ETS) and Carbon Border Adjustment Mechanism (CBAM).
- Supply shortages crimp output in the US and Japan. Chinese growth has been impacted by COVID outbreaks. Eurozone momentum remains intact for now.
- The US attempts to finalise a government spending package. We expect a more forceful policy shift in China. Meanwhile, the Fed heads towards a taper; the ECB has reduced PEPP purchases, but this is not a taper.
- German elections will set the fiscal tone at home and for the Euro area. Japan’s vote will follow the leadership race.
- A mix of negative developments have driven a risk negative tone. Credit spreads remain tight while broader government yields look set to rise gently.
Disclaimer
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.
All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document.
Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.